Author Question: When using a chamber-style adapter with a metered dose inhaler (MDI) to deliver a bronchodi-lator to ... (Read 57 times)

mckennatimberlake

  • Hero Member
  • *****
  • Posts: 559
When using a chamber-style adapter with a metered dose inhaler (MDI) to deliver a bronchodi-lator to a patient receiving mechanical ventilation, with what would you coordinate MDI firing?
 
  a. Beginning of inspiration
  b. Beginning of exhalation
  c. End of inspiration
  d. Middle of inspiration

Question 2

A patient on mechanical ventilation was given 4 puffs of albuterol 5 min ago through a metered dose inhaler (MDI) and holding chamber placed 18 in from the circuit's airway connector.
 
  The patient continues to exhibit clinical signs of increased airway resistance but has demonstrated no apparent side effects from the drug. Which of the following would you recommend at this time?
  a. Discontinue the albuterol and switch to a systemic bronchodilator.
  b. Repeat administration until the desired response is achieved.
  c. Remove the circuit-holding chamber and repeat MDI actuation.
  d. Move the MDI closer to the patient's air-way and repeat use.



vickyvicksss

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

ANS: A
Box 39-9 outlines the optimal technique for drug delivery by pressurized MDI to intubated pa-tients undergoing mechanical ventilation.

Answer to Question 2

ANS: B
Box 39-9 outlines the optimal technique for drug delivery by pressurized MDI to intubated pa-tients undergoing mechanical ventilation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

For a complete list of videos, visit our video library